Article
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.
Journal of clinical immunology - 1 Oct 2021
Bozonnat Alizée, Assan Florence, LeGoff Jérôme, Bourrat Emmanuelle, Bachelez Hervé
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.